Log In
Print
BCIQ
Print
Print this Print this
 

TransCon PEG Growth Hormone (ACP-001)

  Manage Alerts
Collapse Summary General Information
Company Ascendis Pharma A/S
DescriptionOnce-weekly human growth hormone (hGH) prodrug that uses TransCon prodrug technology for sustained release
Molecular Target
Mechanism of ActionInsulin-like growth factor-1 (IGF-1) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationGrowth hormone deficiency
Indication DetailsTreat growth hormone deficiency (GHD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today